DeepScribe and Pearl Health Announce Partnership to Bring Ambient AI Documentation to Value-based Care Providers

Latest DeepScribe partnership brings AI scribe technology and point-of-care intelligence to primary care clinicians participating in ACO REACH and other risk-bearing models

SAN FRANCISCO and NEW YORK, Jan. 14, 2025 /PRNewswire/ — DeepScribe, the ambient AI solution of choice for medical specialties, and Pearl Health, a leading provider of physician enablement and risk management technology and services, today announced DeepScribe as a preferred ambient AI partner for Pearl Health, bringing their technology to the 3,500+ primary care providers using the Pearl Platform.

“Partnering with Pearl Health represents an exciting opportunity to support their mission of helping practices succeed in value-based care,” said Matthew Ko, DeepScribe CEO and Co-founder. “We are eager to contribute to their clinicians’ success by saving them time and delivering point-of-care intelligence that enables them to focus on what matters most: providing exceptional care to their patients.”

Pearl Health’s data analytics and technology help healthcare providers identify patients who are likely to benefit from proactive attention, enabling care teams with insights to better manage large patient panels and deliver timely interventions. DeepScribe will give Pearl Health provider partners more time for patient care and conversation by automatically generating clinical notes for each visit, including the details necessary for accurate, complete billing.

In addition, DeepScribe AI supports continuity of care by intelligently pulling previous notes forward within the context of the current visit, and with real-time recommendations that help guide clinicians during the visit and reduce their cognitive load.

“Ambient scribes reduce the administrative burdens of documentation and coding, so that doctors spend more time engaging with their patients instead of computer screens,” said Matt Solnit, Pearl Health Chief Technology Officer. “The technology aligns perfectly with Pearl’s mission, which is to help providers succeed in VBC using approaches that are empowering instead of overwhelming. When it comes to emerging technologies like AI, our PCPs look to us for guidance. With DeepScribe, our providers get a proven partner already applying its solution to help physicians with value-based initiatives.”

“The need for healthcare organizations taking on risk to capture the full complexity of patient illness cannot be overstated,” said Dean Dalili, MD, MHCM, Chief Medical Officer at DeepScribe. “Bringing a comprehensive patient chart that captures that complexity – with the details and subtleties of patient conversations – to Pearl Health’s insights, gives clinicians a real data advantage to succeed with value-based care. We can’t wait to get started.”

About DeepScribe
DeepScribe helps clinicians make the most of every encounter with ambient AI technology that transforms patient conversations into complete, accurate documentation and real-time insights. DeepScribe’s commitment to excellence was recognized in early 2025 with a 98.8* overall performance score by KLAS Research. Founded in 2017, DeepScribe trains its AI platform to adapt to the specific needs of each specialty, and manage even the most complex medical cases. Working closely with clinicians and healthcare industry leaders, DeepScribe delivers custom AI to ensure greater note accuracy, operational efficiency, and clinician satisfaction. To see how DeepScribe brings the joy of care back to medicine, visit deepscribe.ai.  (*limited data)

About Pearl Health
Pearl Health is powering the future of healthcare. Led by provider enablement, risk-bearing, and technology experts, Pearl offers software and services that help providers reimagine how they visualize, understand, and care for their patients. Pearl supports primary care organizations and providers in their transition to value-based care and surfaces data and insights that help them deliver better, more proactive care, decrease total cost of care across patient panels, and optimize performance in risk-bearing models like Medicare’s ACO REACH. Since its founding in 2020, Pearl has raised approximately $100M in funding from investors such as Andreessen Horowitz, Viking Global Investors, AlleyCorp and SV Angel, and has grown to serve providers across the United States. Learn more at www.pearlhealth.com.

For media inquiries:

Norm Schrager, DeepScribe
norm.schrager@deepscribe.tech
978-771-9976

Madison Klein, Pearl Health
Head of Marketing
562-310-6219
madison.klein@pearlhealth.com

View original content to download multimedia:https://www.prnewswire.com/news-releases/deepscribe-and-pearl-health-announce-partnership-to-bring-ambient-ai-documentation-to-value-based-care-providers-302348410.html

SOURCE DeepScribe

Staff

Recent Posts

KORU Medical Systems Reports Preliminary Fourth Quarter and Full Year 2024 Results; Achieves Record Full Year and Quarterly Revenues; Positive Cash Flow for the Fourth Quarter

MAHWAH, N.J.--(BUSINESS WIRE)--KORU Medical Systems (NASDAQ: KRMD) (“KORU Medical” or the “Company”), a leading medical…

3 hours ago

Glaukos Announces Positive Clinical Updates for its iDose® Sustained-Release Procedural Pharmaceutical Platform

ALISO VIEJO, Calif.--(BUSINESS WIRE)--Glaukos Corporation (NYSE: GKOS), an ophthalmic pharmaceutical and medical technology company focused…

3 hours ago

Viz.ai to Collaborate With Guardant Health to Improve Lung Cancer Detection, Diagnosis, and Treatment

Proposed collaboration aims to integrate cutting-edge AI and genomic insights to advance guideline-directed medical therapySAN…

4 hours ago

NuGen Announces the Appointment of Liang Lin as Chief Executive Officer

Toronto, Ontario--(Newsfile Corp. - January 14, 2025) - NuGen Medical Devices Inc. (TSXV: NGMD) (the…

4 hours ago

Olympus Acquires Distribution Business in Chile

Olympus to sell and distribute its medical technologies directly in Chile and extend its medical…

4 hours ago

Apollo Neuro Partners with GOVX to Better Serve Those Who Serve Us

PITTSBURGH, Jan. 14, 2025 /PRNewswire/ -- Today, Apollo Neuroscience is proud and honored to announce our latest…

4 hours ago